The @ patients were randomized in a double-blinded fashion into @ equal groups to receive immunomodulatory therapy with @ mg/kg celecoxib ( group A ) , @ mg/kg Sou-Medrol ( group B ) , or placebo ( group C ) , given daily from @ days before surgery to @ days after surgery , and the postoperative cancer recurrence were compared .